British Journal of Clinical Pharmacology

Money makes the world go round: the pervasiveness of pharmacoeconomics
pp. 755-757(3)
Author: Ritter, JM

Causality assessment in hepatotoxicity by drugs and dietary supplements
pp. 758-766(9)
Authors: Teschke, Rolf; Schwarzenboeck, Alexander; Hennermann, Karl-Heinz

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?
pp. 767-773(7)
Authors: Golder, Su; Loke, Yoon K.

Is the randomized controlled drug trial in Europe lagging behind the USA?
pp. 774-780(7)
Authors: Heerspink, Hiddo J. Lambers; Knol, Mirjam J.; Tijssen, Robert J. W.; van Leeuwen, Thed N.; Grobbee, Diederick E.; de Zeeuw, Dick

Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure
pp. 781-791(11)
Authors: Halbsguth, Ulrike; Rentsch, Katharina M.; Eich-Höchli, Dominique; Diterich, Isabel; Fattinger, Karin

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
pp. 792-801(10)
Authors: Rolan, Paul; Gibbons, Jacqueline A.; He, Lin; Chang, Eppie; Jones, Drew; Gross, Matthew I.; Davidson, Jennifer Bahr; Sanftner, Laura M.; Johnson, Kirk W.

Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
pp. 802-810(9)
Authors: Kim, Jung-Ryul; Seo, Hyo-Bum; Cho, Joo-Youn; Kang, Do-Hyung; Kim, Yong Ku; Bahk, Won-Myong; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, Jun Soo; Jang, In-Jin

Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib
pp. 811-817(7)
Authors: Schwartz, Jules I.; Agrawal, Nancy G. B.; Wehling, Martin; Musser, Bret J.; Gumbs, Carol P.; Michiels, Nicole; De Smet, Marina; Wagner, John A.

The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range
pp. 818-825(8)
Authors: Kalliokoski, Annikka; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko

Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia
pp. 826-837(12)
Authors: Hawwa, Ahmed F.; Collier, Paul S.; Millership, Jeff S.; McCarthy, Anthony; Dempsey, Sid; Cairns, Carole; McElnay, James C.

Public awareness and views on unlicensed use of medicines in children
pp. 838-845(8)
Authors: Mukattash, T. L.; Millership, J. S.; Collier, P. S.; McElnay, J. C.

Population pharmacokinetics of oral diclofenac for acute pain in children
pp. 846-853(8)
Authors: Standing, Joseph F.; Howard, Richard F.; Johnson, Atholl; Savage, Imogen; Wong, Ian C. K.

The effects and safety of dexibuprofen compared with ibuprofen in febrile children caused by upper respiratory tract infection
pp. 854-860(7)
Authors: Yoon, Jong Seo; Jeong, Dae-Chul; Oh, Jae-Won; Lee, Keun Young; Lee, Hyun Seung; Koh, Young Yull; Kim, Jin Tack; Kang, Jin Han; Lee, Joon Sung

Predictive factors for generalized seizures after deliberate citalopram overdose
pp. 861-865(5)
Authors: Waring, W. Stephen; Gray, Julie A.; Graham, Ann

The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women
pp. 866-874(9)
Authors: Muller, Anouk E.; Dörr, P. Joep; Mouton, Johan W.; De Jongh, Joost; Oostvogel, Paul M.; Steegers, Eric A. P.; Voskuyl, Rob A.; Danhof, Meindert

Initiation and persistence with clopidogrel treatment after acute myocardial infarction - a nationwide study
pp. 875-884(10)
Authors: Sørensen, Rikke; Gislason, G. H.; Fosbøl, E. L.; Rasmussen, S.; Køber, L.; Madsen, J. K.; Torp-Pedersen, C.; Abildstrom, S. Z.

Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model
pp. 885-895(11)
Authors: Kildemoes, Helle Wallach; Støvring, Henrik; Andersen, Morten

QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman
pp. 896-897(2)
Authors: Asajima, Hiroshi; Sekiguchi, Yohei; Matsushima, Shoji; Saito, Naotaka; Saito, Takahiko

Macrolide-theophylline interactions: no role for the inhibition of cytochrome P4501A2
pp. 898-900(3)
Authors: Polasek, Thomas M.; Miners, John O.

Psychological, social and behavioural factors that influence drug efficacy: a noteworthy research subject in clinical pharmacology
pp. 901-902(2)
Authors: Xu, Jing; Mercury, Jeremy; Zhang, Zhongyi; Xu, Feng

Starting with serotonin
pp. 903-904(2)

Translation Section
pp. 905-912(8)

AUTHOR INDEX
pp. 913-921(9)

SUBJECT INDEX
pp. 922-924(3)

Reviewers for 2008
pp. 925-928(4)